瘤免疫微环境在妇科癌症中的癌症
Daniel Margul1, Camilla Yu1, Mariam M AlHilli1
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cleveland Clinic, Cleveland, OH 44195, USA.
Cancers
|August 12, 2023
概括
由于瘤免疫微环境 (TIME) 的差异,在妇科癌症中免疫治疗反应有所不同. 虽然挑战仍然存在,但免疫检查点抑制剂在宫癌和子宫内膜癌方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 妇科 妇科 妇科 妇科
背景情况:
- 妇科癌症对免疫疗法有不同的反应,受分子异质性和瘤免疫微环境 (TIME) 的影响.
- 时间在癌症进展和治疗疗效方面发挥着复杂的双重作用,得到了广泛的临床前研究的支持.
- 了解TIME对于开发针对妇科恶性瘤的有效免疫疗法至关重要.
研究的目的:
- 审查TIME在妇科癌症中的关键特征.
- 探索时代在卵巢,子宫内膜,子宫,和阴道癌症的病理生理学和治疗中的作用.
- 讨论当前的治疗策略和未来利用TIME在妇科瘤学的方向.
主要方法:
- 在妇科癌症的时间临床前和临床研究的文献综述.
- 分析各种免疫成分和目标在 TIME 内的作用.
- 检查当前和新兴的免疫治疗方法,包括免疫检查点抑制剂.
主要成果:
- 在不同的妇科癌症中,TIME存在显著的异质性.
- 临床前数据显示,免疫系统在癌症生长和治疗中的作用是分歧的.
- 免疫检查点抑制剂在宫癌和子宫内膜癌中取得了成功,但挑战仍然存在,特别是在卵巢癌中.
结论:
- 时间是妇科癌症免疫治疗反应的关键决定因素.
- 虽然取得了进展,特别是免疫检查点抑制剂,但需要进一步的研究来克服治疗挑战.
- 识别和验证新的时间向治疗方法对于改善卵巢,子宫内膜,子宫,阴道和阴道癌症的结果至关重要.
关键词:
宫癌:子宫癌是一种癌症.检查点抑制剂检查点抑制剂这是子宫内膜癌的癌症.妇科瘤学妇科瘤学卵巢癌是发生在卵巢的癌症.这就是Pembrolizumab.瘤免疫微环境是一个微环境.瘤透的淋巴细胞.这是阴道癌症.阴道癌是阴道癌的一个类型.更多相关视频
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
18.3K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.7K
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
